The Central Drugs Standard Control Organisation flagged two spurious batches of the widely prescribed blood pressure medication Telma 40 in its May 2025 quality surveillance report. The drug is commonly used to treat hypertension and reduce cardiovascular risk. According to the CDSCO, the flagged samples were collected by a Drugs Inspector in Bihar as part of regular market surveillance.